Celon Pharma SA
WSE:CLN

Watchlist Manager

Celon Pharma SA

WSE:CLN

Watchlist

Dividends

Discount Rate

Price: 27 PLN -0.18%

Market Cap: 1.5B PLN

Have any thoughts about
Celon Pharma SA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication

Add Price Alert

Price Target:

Last Price: 27 PLN

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

CLN Alert

Celon Pharma SA

-0.05 (-0.18%)

52 Week Range	14.22 32.3
Price Target

We'll email you a reminder when the closing price reaches PLN.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Celon Pharma SA

What unique competitive advantages
does Celon Pharma SA hold over its rivals?

What risks and challenges
does Celon Pharma SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Celon Pharma SA.

What unique competitive advantages
does Celon Pharma SA hold over its rivals?

What risks and challenges
does Celon Pharma SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Celon Pharma SA.

Provide P/S
for Celon Pharma SA.

Provide P/E
for Celon Pharma SA.

Provide P/OCF
for Celon Pharma SA.

Provide P/FCFE
for Celon Pharma SA.

Provide P/B
for Celon Pharma SA.

Provide EV/S
for Celon Pharma SA.

Provide EV/GP
for Celon Pharma SA.

Provide EV/EBITDA
for Celon Pharma SA.

Provide EV/EBIT
for Celon Pharma SA.

Provide EV/OCF
for Celon Pharma SA.

Provide EV/FCFF
for Celon Pharma SA.

Provide EV/IC
for Celon Pharma SA.

Show me price targets
for Celon Pharma SA made by professional analysts.

What are the Revenue projections
for Celon Pharma SA?

How accurate were the past Revenue estimates
for Celon Pharma SA?

What are the Net Income projections
for Celon Pharma SA?

How accurate were the past Net Income estimates
for Celon Pharma SA?

What are the EPS projections
for Celon Pharma SA?

How accurate were the past EPS estimates
for Celon Pharma SA?

What are the EBIT projections
for Celon Pharma SA?

How accurate were the past EBIT estimates
for Celon Pharma SA?

Compare the revenue forecasts
for Celon Pharma SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Celon Pharma SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Celon Pharma SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Celon Pharma SA compared to its peers.

Compare the P/E ratios
of Celon Pharma SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Celon Pharma SA with its peers.

Analyze the financial leverage
of Celon Pharma SA compared to its main competitors.

Show all profitability ratios
for Celon Pharma SA.

Provide ROE
for Celon Pharma SA.

Provide ROA
for Celon Pharma SA.

Provide ROIC
for Celon Pharma SA.

Provide ROCE
for Celon Pharma SA.

Provide Gross Margin
for Celon Pharma SA.

Provide Operating Margin
for Celon Pharma SA.

Provide Net Margin
for Celon Pharma SA.

Provide FCF Margin
for Celon Pharma SA.

Show all solvency ratios
for Celon Pharma SA.

Provide D/E Ratio
for Celon Pharma SA.

Provide D/A Ratio
for Celon Pharma SA.

Provide Interest Coverage Ratio
for Celon Pharma SA.

Provide Altman Z-Score Ratio
for Celon Pharma SA.

Provide Quick Ratio
for Celon Pharma SA.

Provide Current Ratio
for Celon Pharma SA.

Provide Cash Ratio
for Celon Pharma SA.

What is the historical Revenue growth
over the last 5 years for Celon Pharma SA?

What is the historical Net Income growth
over the last 5 years for Celon Pharma SA?

What is the current Free Cash Flow
of Celon Pharma SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Celon Pharma SA.

CLN

Balance Sheet

Total Liabilities & Equity

Celon Pharma SA
Total Liabilities & Equity

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

Adjust for Inflation

Celon Pharma SA
Total Liabilities & Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company		Total Liabilities & Equity	CAGR 3Y	CAGR 5Y	CAGR 10Y
C	Celon Pharma SA WSE:CLN	Total Liabilities & Equity zł576.3m	CAGR 3-Years 2%	CAGR 5-Years 0%	CAGR 10-Years N/A
M	Molecure SA WSE:MOC	Total Liabilities & Equity zł112.3m	CAGR 3-Years -10%	CAGR 5-Years 5%	CAGR 10-Years N/A
C	Cannabis Poland SA WSE:CBD	Total Liabilities & Equity zł1.8m	CAGR 3-Years 36%	CAGR 5-Years 18%	CAGR 10-Years N/A

No Stocks Found

Celon Pharma SA
Glance View

Market Cap

1.4B PLN

Industry

Pharmaceuticals

Celon Pharma SA is a pharmaceutical company, which engages in the research and manufacture of modern drugs. The firm focuses on research, development and production of generic drugs for cancer, neurological diseases, diabetes and other metabolic disorders treatment, among others. Its products portfolio comprises pills, such as Aromek, Bosentan Celon, Donepex, Ketrel, Lazivir and Valzek, as well as inhalation powder, such as Salmex. The firm's research center develops pharmaceuticals within a number of therapeutic areas, including oncology, neurology, as well as inflammatory and metabolic diseases. The firm is a subsidiary of Glatton sp z o o.

Open CLN Analysis

CLN Intrinsic Value

9.2 PLN

Overvaluation 66%

Intrinsic Value

Price

What is Intrinsic Value?

What is Celon Pharma SA's Total Liabilities & Equity?

Total Liabilities & Equity
576.3m PLN

Based on the financial report for Jun 30, 2024, Celon Pharma SA's Total Liabilities & Equity amounts to 576.3m PLN.

What is Celon Pharma SA's Total Liabilities & Equity growth rate?

Total Liabilities & Equity CAGR 5Y
0%

Over the last year, the Total Liabilities & Equity growth was -3%. The average annual Total Liabilities & Equity growth rates for Celon Pharma SA have been 2% over the past three years .

Celon Pharma SA
WSE:CLN

Celon Pharma SA
Total Liabilities & Equity

Celon Pharma SA
Total Liabilities & Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Celon Pharma SA
Glance View

See Also

What is Celon Pharma SA's Total Liabilities & Equity?

Total Liabilities & Equity
576.3m PLN

What is Celon Pharma SA's Total Liabilities & Equity growth rate?

Total Liabilities & Equity CAGR 5Y
0%

Company

Help

Tools

Stocks

Celon Pharma SA WSE:CLN

Celon Pharma SA Total Liabilities & Equity

Celon Pharma SA Total Liabilities & Equity Peer Comparison

Competitors Analysis Latest Figures & CAGR of Competitors

Celon Pharma SA Glance View

See Also

What is Celon Pharma SA's Total Liabilities & Equity? Total Liabilities & Equity 576.3m PLN

What is Celon Pharma SA's Total Liabilities & Equity growth rate? Total Liabilities & Equity CAGR 5Y 0%

Company

Help

Tools

Stocks

Celon Pharma SA
WSE:CLN

Celon Pharma SA
Total Liabilities & Equity

Celon Pharma SA
Total Liabilities & Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Celon Pharma SA
Glance View

What is Celon Pharma SA's Total Liabilities & Equity?

Total Liabilities & Equity
576.3m PLN

What is Celon Pharma SA's Total Liabilities & Equity growth rate?

Total Liabilities & Equity CAGR 5Y
0%